Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus

Condition:   Renal Cell Carcinoma Interventions:   Drug: Neoadjuvant Lenvatinib;   Drug: Neoadjuvant Pembrolizumab;   Procedure: Radical nephrectomy, IVC thrombectomy, retroperitoneal lymph node dissection;   Drug: Adjuvant Pembrolizumab Sponsor:   University of Texas Southwestern Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials